ADITXT
(NASDAQ: ADTX)

Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Richmond, VA.

0.186

-0.040 (-17.70%)
Range 0.185 - 0.210   (13.51%)
Open 0.198
Previous Close 0.226
Bid Price 0.570
Bid Volume 31
Ask Price 0.580
Ask Volume 11
Volume 10,602,983
Value -
Remark
Delayed prices. Updated at 21 Dec 2024 05:00.
Data powered by
View All Events


Top Contributors

USNews avatar
347
Followers 277
Posts 1283231

Loading Chart...

Please login to view stock data and analysis